Erratum to: Endogenous soluble receptor of advanced glycation end-products (esRAGE) is negatively associated with vascular calcification in non-diabetic hemodialysis patients

被引:0
|
作者
Mohamed M. NasrAllah
Amal R. El-Shehaby
Noha A. Osman
Mona M. Salem
Amr Nassef
Usama A. A. Sharaf El Din
机构
[1] Cairo University,Department of Nephrology, Kasr El
[2] Cairo University,Aini School of Medicine
[3] Cairo University,Department of Medical Biochemistry, Kasr El
[4] Cairo University,Aini School of Medicine
[5] Cairo University and International Kidney Centre,Department of Endocrinology, Kasr El
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1201 / 1202
页数:1
相关论文
共 50 条
  • [1] Endogenous soluble receptor of advanced glycation end-products (esRAGE) is negatively associated with vascular calcification in non-diabetic hemodialysis patients
    NasrAllah M.M.
    El-Shehaby A.R.
    Osman N.A.
    Salem M.M.
    Nassef A.
    Sharaf El Din U.A.A.
    International Urology and Nephrology, 2012, 44 (4) : 1193 - 1199
  • [2] Endogenous soluble receptor of advanced glycation end-products (esRAGE) is negatively associated with vascular calcification in non-diabetic hemodialysis patients (vol 44, pg 1193, 2012)
    NasrAllah, Mohamed M.
    El-Shehaby, Amal R.
    Osman, Noha A.
    Salem, Mona M.
    Nassef, Amr
    El Din, Usama A. A. Sharaf
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2012, 44 (04) : 1201 - 1202
  • [3] Visfatin and endogenous secretory receptor for advanced glycation end-products in diabetic type 2 and non-diabetic patients undergoing intermittent hemodialysis
    Leszek Niepolski
    Alicja E. Grzegorzewska
    Monika Młot-Michalska
    International Urology and Nephrology, 2010, 42 : 441 - 452
  • [4] Visfatin and endogenous secretory receptor for advanced glycation end-products in diabetic type 2 and non-diabetic patients undergoing intermittent hemodialysis
    Niepolski, Leszek
    Grzegorzewska, Alicja E.
    Mlot-Michalska, Monika
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2010, 42 (02) : 441 - 452
  • [5] CIRCULATING SOLUBLE RECEPTOR OF ADVANCED GLYCATION END PRODUCT (S-RAGE) IS NEGATIVELY ASSOCIATED WITH VASCULAR CALCIFICATION IN HEMODIALYSIS PATIENTS
    Jung, Ji Yong
    Ro, Han
    Lee, Chungsik
    Kim, Sun Moon
    Kim, Ae Jin
    Kim, Hyung Soo
    Chang, Jae Hyun
    Lee, Hyun Hee
    Chung, Wookyung
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 448 - 448
  • [6] Advanced glycation end-products: Implications for diabetic and non-diabetic nephropathies
    Daroux, M.
    Prevost, G.
    Maillard-Lefebvre, H.
    Gaxatte, C.
    D'Agati, V. D.
    Schmidt, A. M.
    Boulanger, E.
    DIABETES & METABOLISM, 2010, 36 (01) : 1 - 10
  • [7] Advanced glycation end-products in senile diabetic and non-diabetic patients with cardiovascular complications
    Gul, Anjuman
    Rahman, M. Ataur
    Salim, Asmat
    Simjee, Shabana U.
    AGE, 2008, 30 (04) : 303 - 309
  • [8] Advanced glycation end-products in senile diabetic and non-diabetic patients with cardiovascular complications
    Anjuman Gul
    M. Ataur Rahman
    Asmat Salim
    Shabana U. Simjee
    AGE, 2008, 30 : 303 - 309
  • [9] Elevated endogenous secretory receptor for advanced glycation end products (esRAGE) levels are associated with circulating soluble RAGE levels in diabetic children
    Saito, Reiko
    Araki, Shunsuke
    Yamamoto, Yukiyo
    Kusuhara, Koichi
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2017, 30 (01): : 63 - 69
  • [10] Decreased levels of soluble receptor for advanced glycation end-products in aortic valve calcification patients
    Zheng, H.
    Li, Y.
    Xie, N.
    Huang, J. L.
    Xu, H. F.
    Luo, M.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02): : 3775 - 3783